Stay updated on ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Sign up to get notified when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Updates the revision/version indicator shown on the page (from “v3.5.2” to “v3.5.3”) with no visible change to the study record content.
    Difference
    0.1%
    Check dated 2026-04-24T06:09:22.000Z thumbnail image
  2. Check
    12 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Removed Revision: v3.5.0.
    Difference
    0.1%
    Check dated 2026-04-17T02:43:41.000Z thumbnail image
  3. Check
    19 days ago
    No Change Detected
  4. Check
    40 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0 on the page history.
    Difference
    0.1%
    Check dated 2026-03-19T05:29:11.000Z thumbnail image
  5. Check
    48 days ago
    Change Detected
    Summary
    New revision v3.4.3 was added to the history and revision v3.4.2 was removed.
    Difference
    0.1%
    Check dated 2026-03-12T00:51:29.000Z thumbnail image
  6. Check
    69 days ago
    Change Detected
    Summary
    A new history entry on 2026-02-18 updates the Study Status. The 2026-01-12 version was removed from the history.
    Difference
    0.3%
    Check dated 2026-02-18T16:17:29.000Z thumbnail image
  7. Check
    76 days ago
    Change Detected
    Summary
    Added a new revision entry (v3.4.2) to the study record history. The notice about government funding status and the older revision entry (v3.4.1) were removed.
    Difference
    0.7%
    Check dated 2026-02-11T14:19:26.000Z thumbnail image

Stay in the know with updates to ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial

Enter your email address, and we'll notify you when there's something new on the ASTX727, Venetoclax, Gilteritinib in FLT3-Mutated AML Clinical Trial page.